Disclosed herein are compositions useful for the treatment and/or prevention of various diseases and conditions, including a variety of infections, via internal administration to a patient. The compositions comprise an effective amount of a halo active aromatic sulfonamide compound having the structure of Formula (I):

##STR00001##

wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5, X, and M are defined herein. The compositions described may be used to treat and/or prevent a variety of infections, including bacterial infections, viral infections, fungal infections, and the like. The compositions can be internally administered to a patient via at least one of: oral administration, pulmonary administration, subcutaneous administration, sublingual administration, ocular administration, otic administration, intravenous administration, inter-dermal administration, epidural administration, intraperitoneal administration, and intramuscular administration.

This invention pertains to an anti-microbial, in particular anti-bacterial, more particularly against Gram negative bacteria, and/or anti-fungal composition comprising as active blend trans-cinnamaldehyde and a potentiating agent. In particular this composition is intended for preventing and/or treating microbial infection in an animal.

The invention relates to ICAN-derivative compounds having the general formula (I), wherein Q is selected from the group consisting of —NC, —NO.sub.2, —NO, —NHOH, —NCS and —NR.sub.1R.sub.2, for use as antifungal agents and gal preparations and pharmaceutical preparations for use in the treatment of a subject in need of antifungal medication.

##STR00001##

The invention relates to ICAN-derivative compounds having the general formula (I), wherein Q is selected from the group consisting of —NC, —NO.sub.2, —NO, —NHOH, —NCS and —NR.sub.1R.sub.2, for use as antifungal agents and gal preparations and pharmaceutical preparations for use in the treatment of a subject in need of antifungal medication.

##STR00001##

A method for acquiring at least one two-dimensional image of a part of arches of a patient includes steps carried out by the patient or other person who is not a dental health professional, for example, including placing a dental separator in the mouth of the patient in order to separate the lips of the patient and improve the visibility of the teeth during the acquisition of said at least one two-dimensional image, and acquiring, in a mouth closed position and with a personal image acquisition apparatus, said at least one two-dimensional image.

The present invention relates to the field of medical care, and it relates to the application of alkaloids and volatile oils contained in plants such as Gastrodia elata, Pinellia ternata, Orange Peel and Uncaria rhynchophylla in the preparation of medicines or health products for treating influenza or infectious diseases caused by viruses or fungi; especially, it relates to new use of the alkaloids and volatile oils contained in raw materials such as Gastrodia elata, Pinellia ternata, Orange Peel, Unearia and other plants in the preparation of drugs or health products for treating influenza or infectious diseases caused by influenza viruses (including HN avian influenza), coronavirus, Ebola virus, AIDS, Aspergillus, Cryptococcus, Mucor, Histoplasma capsulatum, etc.

The present invention relates to the field of medical care, and it relates to the application of alkaloids and volatile oils contained in plants such as Gastrodia elata, Pinellia ternata, Orange Peel and Uncaria rhynchophylla in the preparation of medicines or health products for treating influenza or infectious diseases caused by viruses or fungi; especially, it relates to new use of the alkaloids and volatile oils contained in raw materials such as Gastrodia elata, Pinellia ternata, Orange Peel, Unearia and other plants in the preparation of drugs or health products for treating influenza or infectious diseases caused by influenza viruses (including HN avian influenza), coronavirus, Ebola virus, AIDS, Aspergillus, Cryptococcus, Mucor, Histoplasma capsulatum, etc.

A composition and method directed to the treatment of bacterial infections is provided.

A composition and method directed to the treatment of bacterial infections is provided.

The invention provides compositions featuring chitosan and methods for using such compositions for the local delivery of biologically active agents to an open fracture, complex wound or other site of infection. Advantageously, the degradation and drug elution profiles of the chitosan compositions can be tailored to the needs of particular patients at the point of care (e.g., in a surgical suite, clinic, physician's office, or other clinical setting).